
NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics fell 49.1% from $0.25 to $0.13, behind the S&P 500's +3.2%. Its worst day was Jan 6 (−10.9%), and its low came Nov 20 at $0.13.
Nov 24, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics closed at its highest level of the year, 28.6% above where the year started.
+25.5%, the year's best day · S&P 500 +0.7%
NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics shares rose 10.2%, while the S&P 500 rose 0.2%.
Story events cover the past 12 months · Times ET
+10.2% · S&P 500 +0.2%
NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics shares fell 10.5%, while the S&P 500 rose 0.7%.
−10.5% · S&P 500 +0.7%
NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics shares rose 9.9%, while the S&P 500 fell 1.0%.
+9.9% · S&P 500 −1.0%
NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics shares fell 10.2%, while the S&P 500 fell 0.3%.
−10.2% · S&P 500 −0.3%
NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics shares fell 10.5%, while the S&P 500 fell 1.2%.
−10.5% · S&P 500 −1.2%
Where it ended: a close of $0.13 on Nov 20, 2026.
Nothing in the past 12 months.
All NWBO earningsNothing in the past 12 months.
All NWBO analyst actionsNothing in the past 12 months.
All NWBO dividend historyNothing in the past 12 months.
All NWBO news